As the cycle of uncertainty continues to yield confusion than clarity, investors are again caught having to decide between taking an offensive and defensive...
Sen. Tim Kaine, D-Va., plans to move full steam ahead with his war powers resolution, despite a fragile ceasefire reached Tuesday between Israel and...
Fresh satellite imagery released by Maxar Technologies shows significant damage at three of Iran’s key nuclear sites, Fordow, Natanz, and Isfahan, just days after...
In this edition of StockCharts TV‘s The Final Bar, Dave answers viewer questions on using technical indicators on leveraged and inverse ETFs like SOXL and SOXS,...
In this edition of StockCharts TV‘s The Final Bar, Dave recaps a day where technology shares struggles, with leading names like NVDA and MU dropping bearish...
Editor’s Note: This article was originally published on November 21, 2022. This article has absolutely nothing to do with trend following or the markets....
Gilead Sciences’ (GILD) new HIV prevention shot, lenacapavir, hit it out of the park in a late-stage trial, showing 100% effectiveness. 2,000 women participated...